University adopts INTEGRA pipettes for prestigious international competition

Students of Technische Universität Braunschweig, Germany, used INTEGRA Biosciences’ VIAFLO electronic pipettes and EVOLVE manual pipettes to perform sample transfers and dilutions as part of their project for the 2022 iGEM competition. The pipettes helped the team to speed up liquid handling and increase pipetting accuracy, giving the students a competitive edge over their peers. The iGEM Foundation is an independent, non-profit organization dedicated to the advancement of all areas of synthetic biology.

It runs an annual international competition where multidisciplinary teams of university students design, build and test their own unique research projects from start to finish.

The group at Technische Universität Braunschweig (TU_BS) developed a self-amplifying detection system for the competition, which can be used to identify small amounts of tumor marker antigens in blood samples. This novel tool has the potential to contribute to the early diagnosis and treatment of many cancers, improving patient outcomes and survival rates in the long term.

Benjamin Harder, a student at TU_BS, explained: “We were the first iGEM team at our university for some time so, until recently, we had only a few outdated pipettes available to us. We therefore decided to upgrade to INTEGRA’s VIAFLO electronic pipettes and EVOLVE manual pipettes. They are well suited to our applications, as they allow us to rapidly adjust the dispensing volume on the fly, making our liquid handling steps faster and more efficient than before, while simultaneously minimizing manual errors and reagent wastage. This noticeably improved the accuracy and reproducibility of our results, giving us greater confidence in our findings.”

Every day working on our project in the lab was different and unpredictable, but INTEGRA’s products greatly helped us to deal with some of the surprises and challenges we came across as we got closer to the final of the exciting competition,” Benjamin concluded. All teams presented their cutting-edge projects during the iGEM Grand Jamboree in Paris, France, from the 26th to the 28th of October 2022, with prize winners being announced on the final day. TU_BS was awarded a silver medal for their innovative project, a much-deserved reward for the group’s months of hard work.

Visit the INTEGRA Biosciences website to learn more.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2023, January 26). University adopts INTEGRA pipettes for prestigious international competition. News-Medical. Retrieved on April 16, 2024 from https://www.news-medical.net/news/20230112/University-adopts-INTEGRA-pipettes-for-prestigious-international-competition.aspx.

  • MLA

    INTEGRA Biosciences. "University adopts INTEGRA pipettes for prestigious international competition". News-Medical. 16 April 2024. <https://www.news-medical.net/news/20230112/University-adopts-INTEGRA-pipettes-for-prestigious-international-competition.aspx>.

  • Chicago

    INTEGRA Biosciences. "University adopts INTEGRA pipettes for prestigious international competition". News-Medical. https://www.news-medical.net/news/20230112/University-adopts-INTEGRA-pipettes-for-prestigious-international-competition.aspx. (accessed April 16, 2024).

  • Harvard

    INTEGRA Biosciences. 2023. University adopts INTEGRA pipettes for prestigious international competition. News-Medical, viewed 16 April 2024, https://www.news-medical.net/news/20230112/University-adopts-INTEGRA-pipettes-for-prestigious-international-competition.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Accelerating antibody therapy with INTEGRA pipettes